PSYCHIATRIC DISORDERS REPORTED ON CHANTIX?

The United States has gradually woken up to the high health hazards of smoking, with approximately 75 percent of the smokers in the country wishing to quit smoking.

Realizing that it has the most easily avoidable reason for mortality, city and state governments have passed numerous anti-smoking laws. This, along with the introduction of Chantix, the first smoking cessation drug in almost a decade, has given a huge boost to the smoking cessation medication market.

New analysis from Frost & Sullivan (http://www.pharma.frost.com), U.S. Smoking Cessation Market, finds that the market earned revenues of $111.5 million in 2006 and estimates this to reach $1,532.6 million in 2013. [...]